These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33539036)

  • 1. Improved periviability in Japan and dilemmas for non-communicable diseases in the COVID-19 era.
    Malamitsi-Puchner A
    Acta Paediatr; 2021 May; 110(5):1696. PubMed ID: 33539036
    [No Abstract]   [Full Text] [Related]  

  • 2. Fighting non-communicable diseases in the COVID-19 era: a catch 22?
    Ennezat PV; Guerbaai RA
    Acta Cardiol; 2022 Jun; 77(4):366-367. PubMed ID: 33685339
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcomes of infants born at periviable gestations in Japan.
    Kono Y; Rysavy MA; Nakanishi H; Kusuda S
    Acta Paediatr; 2021 May; 110(5):1694-1695. PubMed ID: 33538359
    [No Abstract]   [Full Text] [Related]  

  • 4. Recognizing the roles of primary health care in addressing non-communicable diseases in low- and middle-income countries: Lesson from COVID-19, implications for the future.
    Yadav UN; Mistry SK; Ghimire S; Schneider CH; Rawal LB; Acharya SP; Harris-Roxas B; Harris MF
    J Glob Health; 2021; 11():03120. PubMed ID: 34804511
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention and control of non-communicable diseases in the COVID-19 response.
    Kluge HHP; Wickramasinghe K; Rippin HL; Mendes R; Peters DH; Kontsevaya A; Breda J
    Lancet; 2020 May; 395(10238):1678-1680. PubMed ID: 32401713
    [No Abstract]   [Full Text] [Related]  

  • 6. Twin epidemics of covid-19 and non-communicable disease.
    Sheldon TA; Wright J
    BMJ; 2020 Jun; 369():m2618. PubMed ID: 32605906
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 Pandemic and Burden of Non-Communicable Diseases: An Ecological Study on Data of 185 Countries.
    Azarpazhooh MR; Morovatdar N; Avan A; Phan TG; Divani AA; Yassi N; Stranges S; Silver B; Biller J; Tokazebani Belasi M; Kazemi Neya S; Khorram B; Frydman A; Nilanont Y; Onorati E; Di Napoli M
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105089. PubMed ID: 32807484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International collaboration and covid-19: what are we doing and where are we going?
    Bump JB; Friberg P; Harper DR
    BMJ; 2021 Jan; 372():n180. PubMed ID: 33509953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and non-communicable diseases in the Eastern Mediterranean Region: the need for a syndemics approach to data reporting and healthcare delivery.
    Nassereddine G; Habli S; Slama S; Sen K; Rizk A; Sibai AM
    BMJ Glob Health; 2021 Jun; 6(6):. PubMed ID: 34103327
    [No Abstract]   [Full Text] [Related]  

  • 10. The Impact of COVID-19 on Non-Communicable Diseases.
    Haileamlak A
    Ethiop J Health Sci; 2022 Jan; 32(1):1-2. PubMed ID: 35250211
    [No Abstract]   [Full Text] [Related]  

  • 11. The COVID-19 pandemic offers a key moment to reflect on travel medicine practice.
    Hatz C; Bühler S; Farnham A
    J Travel Med; 2020 Dec; 27(8):. PubMed ID: 32877520
    [No Abstract]   [Full Text] [Related]  

  • 12. Hospital Admissions Associated With Noncommunicable Diseases During the COVID-19 Outbreak in Brazil.
    Maselli-Schoueri JH; de Carvalho LEW; Rezende LFM; Fonseca FLA; Ferrari G; Adami F
    JAMA Netw Open; 2021 Mar; 4(3):e210799. PubMed ID: 33683330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loneliness and social isolation during the COVID-19 pandemic.
    Hwang TJ; Rabheru K; Peisah C; Reichman W; Ikeda M
    Int Psychogeriatr; 2020 Oct; 32(10):1217-1220. PubMed ID: 32450943
    [No Abstract]   [Full Text] [Related]  

  • 14. A Syndemic Perspective on the Management of Non-communicable Diseases Amid the COVID-19 Pandemic in Low- and Middle-Income Countries.
    Yadav UN; Rayamajhee B; Mistry SK; Parsekar SS; Mishra SK
    Front Public Health; 2020; 8():508. PubMed ID: 33102414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial Risk Factors, Noncommunicable Diseases, and Animal Models for COVID-19.
    Bartolomucci A; Sapolsky RM
    Biol Psychiatry; 2021 Jun; 89(12):e67-e71. PubMed ID: 33487440
    [No Abstract]   [Full Text] [Related]  

  • 16. The alarming burden of non-communicable diseases in COVID-19 new normal: Implications on oral health.
    Riad A; Boccuzzi M; Pold A; Krsek M
    Oral Dis; 2021 Apr; 27 Suppl 3(Suppl 3):791-792. PubMed ID: 32557995
    [No Abstract]   [Full Text] [Related]  

  • 17. An Implementation Framework for Telemedicine to Address Noncommunicable Diseases in Thailand.
    Chattranukulchai P; Thongtang N; Ophascharoensuk V; Muengtaweepongsa S; Angkurawaranon C; Chalom K; Supungul S; Thammatacharee J; Kittikhun S; Shantavasinkul PC; Leelahavarong P; Rawdaree P; Tangsawad S; Pitayarangsarit S; Kanaderm C; Assawamakin A; Roubsanthisuk W; Sukonthasarn A
    Asia Pac J Public Health; 2021 Nov; 33(8):968-971. PubMed ID: 33870725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Ounce of Prevention Is Still Worth a Pound of Cure, Especially in the Time of COVID-19.
    Hacker KA; Briss PA
    Prev Chronic Dis; 2021 Jan; 18():E03. PubMed ID: 33411667
    [No Abstract]   [Full Text] [Related]  

  • 19. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.
    Palmer K; Monaco A; Kivipelto M; Onder G; Maggi S; Michel JP; Prieto R; Sykara G; Donde S
    Aging Clin Exp Res; 2020 Jul; 32(7):1189-1194. PubMed ID: 32458356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interplay between COVID 19 and non-communicable diseases.
    Chaturvedi S; Gorelick P
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105104. PubMed ID: 32653107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.